Shane Climie, Ph.D.

Shane Climie has more than 20 years of R&D and business development experience in the life sciences and pharmaceutical industry. He has led research teams involved in all aspects of drug discovery and has designed, negotiated and managed many R&D collaborations. He also has extensive experience in technology evaluation, technology development, and strategic planning.

Most recently, Dr. Climie held several positions at Protana Inc. (formerly MDS Proteomics), including Senior Vice President, Science Strategy and Business Development; Senior Vice President, Research Collaborations; and Vice President, Proteomics and Business Development. From 1999 to 2000, Dr. Climie was co-founder, Vice President and Chief Technology Officer of MDS Ocata. In 1999 he served as a Visiting Research Scientist at the Samuel Lunenfeld Research Institute. From 1990 to 1999, he held several positions at Allelix Biopharmaceuticals, Inc. (now NPS Allelix Inc., Nasdaq:NPSP), including Principal Scientist, Manager of New Technologies, and Manager of Molecular and Structural Biology.

Dr. Climie was a postdoctoral scholar at the University of California at San Francisco. He received a Ph.D. in medical biophysics from the University of Toronto and a B.Sc. in biology from the University of Waterloo.